Ishika Saha

Ms. Ishika Saha

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ISIshika Saha
Ishika Saha
EDEric K. Dang
Eric K. Dang
DSDennis Svatunek
Dennis Svatunek
KHKendall N Houk
Kendall N Houk
PHPatrick G Harran
Patrick G Harran
Significance: We describe computations to anticipate products of multistep reaction sequences. The work is based on experimental methods developed earlier to amalgamate synthetic scaffolding reagents with small linear peptides. Hybrid products retain molecular recognition elements in the peptide, but display that functionality as part of amphipathic macrocycles having defined conformations and improved pharmacological properties. The hypothetical scope of the chemistry is large and far outpaces the experimental format. To explore the structure space more extensively, we devised algorithms to predict outcomes of more than 2 billion processing sequences. Software was also developed to generate accurate three-dimensional structures for each product. The resultant virtual library is a resource that can be deployed broadly in search of novel ligands for protein receptors.

15 December 2021 in Molecules
Verified
Journal Article
Open access
PDF file
EMEmily S. Murzinski
Emily S. Murzinski
ISIshika Saha
Ishika Saha
HDHui Ding
Hui Ding
DSDavid Strugatsky
David Strugatsky
RHRyan A. Hollibaugh
Ryan A. Hollibaugh
PHPatrick G Harran
Patrick G Harran
Ghrelin is a 28-residue peptide hormone produced by stomach P/D1 cells located in oxyntic glands of the fundus mucosa. Post-translational octanoylation of its Ser-3 residue, catalyzed by MBOAT4 (aka ghrelin O-acyl transferase (GOAT)), is essential for the binding of the hormone to its receptor in target tissues. Physiological roles of acyl ghrelin include the regulation of food intake, growth hormone secretion from the pituitary, and inhibition of insulin secretion from the pancreas. Here, we describe a medicinal chemistry campaign that led to the identification of small lipopeptidomimetics that inhibit GOAT in vitro. These molecules compete directly for substrate binding. We further describe the synthesis of heterocyclic inhibitors that compete at the acyl coenzyme A binding site.

23 September 2024 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
GCGabriella I. D. Cooper
Gabriella I. D. Cooper
ISIshika Saha
Ishika Saha
JNJacob Newman
Jacob Newman
RSRuthy H. Shin
Ruthy H. Shin
PHPatrick G Harran
Patrick G Harran

27 November 2023 in Chemical Science
Verified
Journal Article
Open access
PDF file
KPKunlayanee Punjajom
Kunlayanee Punjajom
PSPaul P. Sinclair
Paul P. Sinclair
ISIshika Saha
Ishika Saha
MSMark Seierstad
Mark Seierstad
MAMichael K. Ameriks
Michael K. Ameriks
RSRichmond Sarpong
Richmond Sarpong
We report the modular preparation of dihydro-1,2,5-thiodiazole dioxide heterocycles starting from methyl ketones and primary amines. This one-pot, three-component coupling employs 2,3-dimethylimidazole-1-sulfonyl azide triflate as a coupling reagent and oxidant. The transformation is scalable and various ketones and amines can be used, yielding thiodiazole dioxide products in up to 89% yield. In addition, 15N- and 13C-labeling studies suggest a mechanism involving a 1,2-nitrogen migration. Together with the mechanistic studies, DFT calculations provide insight into the reaction pathway and set the stage for further exploration of the mechanistic nuances of reactions that use sulfamoyl azides. In combination with the demonstrated modularity of the approach reported herein, the derivatization of the thiodiazole dioxide products highlights the potential of this methodology to rapidly access diverse chemical structures.

12 May 2021
Verified
Book
Closed access
ISIshika Saha
Ishika Saha
PHPatrick G Harran
Patrick G Harran